RESOURCES
I. NANOBIOSENSORS ARRAY
1. Ultrasensitive label-free DNA analysis using an electronic chip based on carbon nanotube nanoelectrode arrays.Jessica Koehne et al 2003 Nanotechnology 14 1239. https://doi.org/10.1088/0957-4484/14/12/001
2. Wafer-scale fabrication of patterned carbon nanofiber nanoelectrode arrays: A route for development of multiplexed, ultrasensitive disposable biosensors. Prabhu U.Arumugam,,HuaChen, Shabnam Siddiqui, Jarret A.P.Weinrich, Ayodeji Jejelowo, Jun Li, M.Meyyappan, Biosensors and Bioelectronics, 2009. https://doi.org/10.1016/j.bios.2009.02.009
3. Miniaturized Multiplex Label-Free Electronic Chip for Rapid Nucleic Acid Analysis Based on Carbon Nanotube Nanoelectrode Arrays. Jessica E. Koehne, Hua Chen, Alan M. Cassell, Qi Ye, Jie Han, Meyya Meyyappan, Jun Li, Clinical Chemistry Oct 2004, 50 (10) 1886-1893; https://doi.org/10.1373/clinchem.2004.036285
4. Multiplexed electrochemical immunosensor for label-free detection of cardiac markers using a carbon nanofiber array chip. Rakesh K. Gupta, Ruchi Pandya, Theodore Sieffert, M. Meyyappan, Jessica E. Koehne. Journal of Electroanalytical Chemistry Volume 773, 2016, 53-62 https://doi.org/10.1016/j.jelechem.2016.04.034
5. Label-Free Detection of Cardiac Troponin-I Using Carbon Nanofiber Based Nanoelectrode Arrays. Adaikkappan Periyakaruppan, Ram P. Gandhiraman, M. Meyyappan, and Jessica E. Koehne. Analytical Chemistry 2013 85 (8), 3858-3863. https://doi.org/10.1021/ac302801z
6. Vertically aligned carbon nanofibernanoelectrode arrays: electrochemical etching and electrode reusability.
Rakesh K. Guptaa, M. Meyyappan, and Jessica E. Koehne. RSC Adv. 2014. https://doi.org/10.1039/C4RA01779J
II. ACUTE MYOCARDIAL INFARCTION RULEOUT
1. Fourth Universal Definition of Myocardial Infarction, 2018, Kristian Thygesen, Joseph S. Alpert, Allan S. Jaffe, Bernard R. Chaitman, Jeroen J. Bax, David A. Morrow, Harvey D. White and Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction. https://doi.org/10.1016/j.gheart.2018.08.004
2. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Roffi M, Patrono C, Collet JP, et al.Eur Heart J 2016; 37: 267–315. https://doi.org/10.1093/eurheartj/ehv320
3. Being Rational about (Im)precision: A Statement from the Biochemistry Subcommittee of the Joint European Society of Cardiology/American College of Cardiology Foundation/American Heart Association/World Heart Federation Task Force for the Definition of Myocardial Infarction. Allan S. Jaffe, Fred S. Apple, David A. Morrow, Bertil Lindahl, Hugo A. Katus, Clinical Chemistry Jun 2010, 56 (6) 941-943; https://doi.org/10.1373/clinchem.2010.143958
4. Improving the 510(k) FDA Process for Cardiac Troponin Assays: In Search of Common Ground. Fred S. Apple, Judd Hollander, Alan H.B. Wu, Allan S. Jaffe, Clinical Chemistry Oct 2014, 60 (10) 1273-1275; https://doi.org/10.1373/clinchem.2014.229286
5. Copeptin Helps in the Early Detection of Patients With Acute Myocardial Infarction Primary Results of the CHOPIN Trial (Copeptin Helps in the early detection Of Patients with acute myocardial INfarction).Journal of the American College of Cardiology Vol. 62, No. 2, 2013, https://doi.org/10.1016/j.jacc.2013.04.011
6. Copeptin Improves Early Diagnosis of Acute Myocardial Infarction. Journal of the American College of Cardiology Vol. 55, No. 19, 2010, https://doi.org/10.1016/j.jacc.2010.01.029
7. Martin Möckel, Julia Searle, Christian Hamm, Anna Slagman, Stefan Blankenberg, Kurt Huber, Hugo Katus, Christoph Liebetrau, Christian Müller, Reinhold Muller, Philipp Peitsmeyer, Johannes von Recum, Milos Tajsic, Jörn O. Vollert, Evangelos Giannitsis, Early discharge using single cardiac troponin and copeptin testing in patients with suspected acute coronary syndrome (ACS): a randomized, controlled clinical process study, European Heart Journal, Volume 36, Issue 6, 7 February 2015, Pages 369–376, https://doi.org/10.1093/eurheartj/ehu178
8. Reinhold T, Giannitsis E, Möckel M, Frankenstein L, Vafaie M, Vollert JO, et al. (2018) Cost analysis of early discharge using combined copeptin/cardiac troponin testing versus serial cardiac troponin testing in patients with suspected acute coronary syndrome. PLoS ONE 13(8): e0202133. https://doi.org/10.1371/journal.pone.0202133
9. Mueller, C., Möckel, M., Giannitsis, E., Huber, K., Mair, J., Plebani, M., … Lindahl, B. (2018). Use of copeptin for rapid rule-out of acute myocardial infarction. European Heart Journal: Acute Cardiovascular Care, 7(6), 570–576. https://doi.org/10.1177/2048872617710791
1. Ultrasensitive label-free DNA analysis using an electronic chip based on carbon nanotube nanoelectrode arrays.Jessica Koehne et al 2003 Nanotechnology 14 1239. https://doi.org/10.1088/0957-4484/14/12/001
2. Wafer-scale fabrication of patterned carbon nanofiber nanoelectrode arrays: A route for development of multiplexed, ultrasensitive disposable biosensors. Prabhu U.Arumugam,,HuaChen, Shabnam Siddiqui, Jarret A.P.Weinrich, Ayodeji Jejelowo, Jun Li, M.Meyyappan, Biosensors and Bioelectronics, 2009. https://doi.org/10.1016/j.bios.2009.02.009
3. Miniaturized Multiplex Label-Free Electronic Chip for Rapid Nucleic Acid Analysis Based on Carbon Nanotube Nanoelectrode Arrays. Jessica E. Koehne, Hua Chen, Alan M. Cassell, Qi Ye, Jie Han, Meyya Meyyappan, Jun Li, Clinical Chemistry Oct 2004, 50 (10) 1886-1893; https://doi.org/10.1373/clinchem.2004.036285
4. Multiplexed electrochemical immunosensor for label-free detection of cardiac markers using a carbon nanofiber array chip. Rakesh K. Gupta, Ruchi Pandya, Theodore Sieffert, M. Meyyappan, Jessica E. Koehne. Journal of Electroanalytical Chemistry Volume 773, 2016, 53-62 https://doi.org/10.1016/j.jelechem.2016.04.034
5. Label-Free Detection of Cardiac Troponin-I Using Carbon Nanofiber Based Nanoelectrode Arrays. Adaikkappan Periyakaruppan, Ram P. Gandhiraman, M. Meyyappan, and Jessica E. Koehne. Analytical Chemistry 2013 85 (8), 3858-3863. https://doi.org/10.1021/ac302801z
6. Vertically aligned carbon nanofibernanoelectrode arrays: electrochemical etching and electrode reusability.
Rakesh K. Guptaa, M. Meyyappan, and Jessica E. Koehne. RSC Adv. 2014. https://doi.org/10.1039/C4RA01779J
II. ACUTE MYOCARDIAL INFARCTION RULEOUT
1. Fourth Universal Definition of Myocardial Infarction, 2018, Kristian Thygesen, Joseph S. Alpert, Allan S. Jaffe, Bernard R. Chaitman, Jeroen J. Bax, David A. Morrow, Harvey D. White and Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction. https://doi.org/10.1016/j.gheart.2018.08.004
2. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Roffi M, Patrono C, Collet JP, et al.Eur Heart J 2016; 37: 267–315. https://doi.org/10.1093/eurheartj/ehv320
3. Being Rational about (Im)precision: A Statement from the Biochemistry Subcommittee of the Joint European Society of Cardiology/American College of Cardiology Foundation/American Heart Association/World Heart Federation Task Force for the Definition of Myocardial Infarction. Allan S. Jaffe, Fred S. Apple, David A. Morrow, Bertil Lindahl, Hugo A. Katus, Clinical Chemistry Jun 2010, 56 (6) 941-943; https://doi.org/10.1373/clinchem.2010.143958
4. Improving the 510(k) FDA Process for Cardiac Troponin Assays: In Search of Common Ground. Fred S. Apple, Judd Hollander, Alan H.B. Wu, Allan S. Jaffe, Clinical Chemistry Oct 2014, 60 (10) 1273-1275; https://doi.org/10.1373/clinchem.2014.229286
5. Copeptin Helps in the Early Detection of Patients With Acute Myocardial Infarction Primary Results of the CHOPIN Trial (Copeptin Helps in the early detection Of Patients with acute myocardial INfarction).Journal of the American College of Cardiology Vol. 62, No. 2, 2013, https://doi.org/10.1016/j.jacc.2013.04.011
6. Copeptin Improves Early Diagnosis of Acute Myocardial Infarction. Journal of the American College of Cardiology Vol. 55, No. 19, 2010, https://doi.org/10.1016/j.jacc.2010.01.029
7. Martin Möckel, Julia Searle, Christian Hamm, Anna Slagman, Stefan Blankenberg, Kurt Huber, Hugo Katus, Christoph Liebetrau, Christian Müller, Reinhold Muller, Philipp Peitsmeyer, Johannes von Recum, Milos Tajsic, Jörn O. Vollert, Evangelos Giannitsis, Early discharge using single cardiac troponin and copeptin testing in patients with suspected acute coronary syndrome (ACS): a randomized, controlled clinical process study, European Heart Journal, Volume 36, Issue 6, 7 February 2015, Pages 369–376, https://doi.org/10.1093/eurheartj/ehu178
8. Reinhold T, Giannitsis E, Möckel M, Frankenstein L, Vafaie M, Vollert JO, et al. (2018) Cost analysis of early discharge using combined copeptin/cardiac troponin testing versus serial cardiac troponin testing in patients with suspected acute coronary syndrome. PLoS ONE 13(8): e0202133. https://doi.org/10.1371/journal.pone.0202133
9. Mueller, C., Möckel, M., Giannitsis, E., Huber, K., Mair, J., Plebani, M., … Lindahl, B. (2018). Use of copeptin for rapid rule-out of acute myocardial infarction. European Heart Journal: Acute Cardiovascular Care, 7(6), 570–576. https://doi.org/10.1177/2048872617710791